Abridge is a privately held healthcare AI company that builds ambient-AI clinical documentation and conversation-summarization tools used by physicians, nurses, and health systems. The platform listens to patient-clinician encounters and automatically generates structured clinical notes, billing codes, and patient summaries. In June 2026, Abridge announced parallel strategic partnerships with Nvidia (for compute infrastructure) and Eli Lilly (to deploy its platform in Lilly-sponsored clinical trial recruitment and consent workflows).
Company Info
Funding & Investor Relations
Not publicly disclosed; private AI-health company with significant strategic investor base.
Upcoming Milestones & Key Dates
First deployments of Abridge Clinical Trial Suite in Lilly-sponsored trials
Continued Nvidia compute-infrastructure integration for model training and inference
Clinical Development Pipeline
Recent News
STAT examines whether Abridge's marketing as 'patient-centered' AI lives up to the claim, given its clinician-focused ambient documentation product and recent deals with Nvidia and Eli Lilly.
Eli Lilly has taken a strategic stake in Abridge, the ambient-AI clinical documentation startup, with a focus on accelerating patient identification and consent workflows in Lilly-sponsored clinical trials.
Leadership Team
Co-Founder and Chief Executive Officer
Co-Founder and Chief Technology Officer
Chief Operating Officer
Careers & Job Openings